Sr. Correspondent, Broker Research, Bangalore, India
Saqib's Feed
Jun 12, 2015

Healthcare investors see no threat from Supreme Court

NEW YORK (Reuters) – Investors are betting that the healthcare sector’s strong run will not be held back for long even if the U.S. Supreme Court rules against the Affordable Care Act.

The court will meet next on Monday, though may not issue a ruling on King v. Burwell, a challenge to President Barack Obama’s signature healthcare reform legislation, until later this month.

Jun 12, 2015

Wall St Week Ahead-Healthcare investors see no threat from U.S. Supreme Court

NEW YORK, June 12 (Reuters) – Investors are betting that the
healthcare sector’s strong run will not be held back for long
even if the U.S. Supreme Court rules against the Affordable Care
Act.

The court will meet next on Monday, though may not issue a
ruling on King v. Burwell, a challenge to President Barack
Obama’s signature healthcare reform legislation, until later
this month.

May 29, 2015

Options on Greece ETF look bullish ahead of IMF deadline

NEW YORK, May 29 (Reuters) – Negotiations between Greece and
its lenders has entered a crucial stage, with dire warnings
daily that the country could run out of cash, but U.S. options
market investors actually seem optimistic about a resolution.

Options activity in Global X FTSE Greece 20 exchange traded
fund, which tracks the Greek equity market, has been
dominated by bullish bets throughout May, a sign investors
expect the ongoing debt standoff to be resolved with relative
ease.

May 27, 2015

Broadcom call buying surges on report of deal with Avago

NEW YORK (Reuters) – News that chipmaker Broadcom Corp is in talks to be bought by Avago Technologies Ltd spurred a flurry of trades in Broadcom’s short-term calls, and timely buyers of the options could reap huge gains.

Broadcom shares rallied 18 percent to $55.35 and Avago rose more than 8 percent to $141.40 on Wednesday, after the Wall Street Journal reported that the two companies are in talks for a potential deal. A deal could come as early as this week, two people familiar with the talks told Reuters.

May 1, 2015

McDonald’s shares poised for big move; bullish bets rise

NEW YORK (Reuters) – Options traders appear poised for a big move in McDonald’s Corp’s (MCD.N: Quote, Profile, Research, Stock Buzz) shares as the world’s biggest restaurant chain is set to unveil a much-awaited turnaround plan on Monday, and bullish bets have picked up in recent days.

McDonald’s shares have struggled in the last year as the company faces consumers’ changing tastes and growing preference for healthier fare over processed fast food.

Apr 24, 2015

Investors seek protection against healthcare stock decline

NEW YORK (Reuters) – Healthcare companies on a seven-year tear have been top performers so far in 2015, helping to push broad stock indexes to record levels, but traders are now looking to protect themselves from a selloff as they await major earnings reports in the sector.

Companies reporting first-quarter earnings next week include Bristol-Meyers Squibb Co, Boston Scientific Corp, Merck & Co, Pfizer Inc, Gilead Sciences Inc and Celgene Corp.

Apr 24, 2015

Wall St Week Ahead-Investors seek protection against healthcare stock decline

NEW YORK, April 24 (Reuters) – Healthcare companies on a
seven-year tear have been top performers so far in 2015, helping
to push broad stock indexes to record levels, but traders are
now looking to protect themselves from a selloff as they await
major earnings reports in the sector.

Companies reporting first-quarter earnings next week include
Bristol-Meyers Squibb Co, Boston Scientific Corp
, Merck & Co, Pfizer Inc, Gilead Sciences
Inc and Celgene Corp.

Apr 17, 2015

Options market sees Celladon heart drug as all-or-nothing bet

NEW YORK (Reuters) – Celladon Corp’s shares could either double in value or collapse over the next four weeks after the drug developer announces results from a heart failure gene therapy trial, options data shows.

Later this month, Celladon is expected to report results from a mid-stage study of Mydicar, its experimental gene therapy for advanced heart failure, a condition in which the heart muscle cannot pump enough blood to meet the body’s needs.

Apr 16, 2015

BATS plans to open second U.S. options exchange in November

NEW YORK (Reuters) – Exchange operator BATS Global Markets said on Thursday it plans to open a second options bourse in November as it tries to capture a larger share of the U.S. options market.

BATS Global Markets filed an application with the U.S. Securities and Exchange Commission to launch the new exchange, EDGX Options, an addition to its existing BATS Options platform.

Apr 16, 2015

BATS to file for second U.S. options exchange

NEW YORK, April 16 (Reuters) – Exchange operator BATS Global
Markets said on Thursday it plans to open a second options
bourse in November as it tries to capture a larger share of the
U.S. options market.

BATS Global Markets said it will file an application on
Thursday with the U.S. Securities and Exchange Commission to
launch a new exchange called EDGX Options, an addition to its
existing BATS Options platform.

    • About Saqib

      "Saqib Ahmed is an options correspondent working with the Markets team in New York. He previously led the Reuters Broker Research team in Bangalore. He joined Reuters in 2009 after graduating from the Asian College of Journalism."
      Joined Reuters:
      2009
      Languages:
      English, Hindi, Bengali
    • More from Saqib

    • Contact Saqib

    • Follow Saqib